Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women
Molecular Genetics & Genomic Medicine · 2024-01 · 12 (1)
DOI: 10.1002/mgg3.2359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 18.01.2024. Verfasst von Lijun Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Science and Technology Innovation Committee, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Background
To determine the carrier frequency of, and evaluate a carrier screening program for, spinal muscular atrophy (SMA) in reproductive age women in Shenzhen area.
Methods
A staged screening procedure was used to perform carrier screening for SMA in 22,913 Chinese reproductive age women between 2019 and 2022 in Shenzhen area of China. First, the copy number of exon 7 in the SMN1 gene were detected in women of reproductive age using real‐time quantitative polymerase chain reaction. If SMA carriers were detected, their spouses were then recommended to test. Prenatal diagnosis was carried out in couples who were both carriers.
Results
A total of 389 women were found to be SMA carriers (1.70%, 95% CI: 1.53%–1.87%), indicating the carrier prevalence was approximately 1:59. Despite the proportion of nonpregnant women increased from 37.96% in 2019 to 58.18% in 2022 ( p < 0.05) among the 22,913 reproductive age women, the recall rate of spouses was still not high (62.21%, 95% CI: 57.39%–67.03%). Eight partners were found to be SMA carriers and two fetuses were determined to have SMA with no copies of the SMN1 gene.
Conclusion
Although the acceptability and awareness of SMA carrier screening in Chinese population has increased in recent years, it still fails to reach the ideal expectation. Our experience may provide a basis for and facilitate the popularization of SMA carrier screening in Shenzhen area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, Guangdong, China.
- Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Förderung
- Shenzhen Science and Technology Innovation Committee
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Zhang, L., Mo, J., Zhou, L., Xu, X., Xu, Z., Zhang, L., & Wu, W. (2024). Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women. Molecular Genetics & Genomic Medicine, 12(1). https://doi.org/10.1002/mgg3.2359
Vancouver
Zhang L, Mo J, Zhou L, Xu X, Xu Z, Zhang L, et al. Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women. Molecular Genetics & Genomic Medicine. 2024;12(1). doi:10.1002/mgg3.2359
BibTeX
@article{Zhang2024,
author = {Zhang, Lijun and Mo, Junluan and Zhou, Lu and Xu, Xiaoxin and Xu, Zhiyong and Zhang, Lei and Wu, Weiqing},
title = {Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
volume = {12},
number = {1},
doi = {10.1002/mgg3.2359}
}
EUVIMED